CJC-1295 (without DAC) is a growth hormone–releasing hormone (GHRH) analog examined for its potential to stimulate endogenous growth hormone secretion in controlled research environments. Without the DAC modification, it has a shorter half-life, allowing researchers to study more frequent pulsatile GH release patterns. This peptide is often evaluated alongside GHRPs to explore synergistic effects on GH secretion.
